2024-16831. Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Class II Special Controls: Automated Blood Cell Separator Device Operating by Centrifugal or Filtration Principle
Table 1—Estimated Annual Reporting Burden 1
Recommended activity; guidance section Number of respondents Number of responses per respondent Total annual responses Average burden per response Total hours Annual Report; Section VI, Special Controls 3 1 3 5 15 1 There are no capital costs or operating and maintenance costs associated with this collection of information.
Document Information
- Published:
- 07/31/2024
- Department:
- Food and Drug Administration
- Entry Type:
- Notice
- Action:
- Notice.
- Document Number:
- 2024-16831
- Dates:
- Submit written comments (including recommendations) on the collection of information by August 30, 2024.
- Pages:
- 61429-61430 (2 pages)
- Docket Numbers:
- Docket No. FDA-2024-N-2019
- PDF File:
- 2024-16831.pdf